Joint TOS/OMA/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach
Obesity is a chronic, often progressive, disease requiring comprehensive, long-term, and person-centered care. Effective obesity medications exist but remain underutilized due to systemic barriers. Expanding access, reducing stigma, and ensuring equitable coverage are essential to translating scientific advances into population health gains. Future priorities include access and integration of comprehensive obesity care in the primary care setting, improving affordability, addressing research gaps, conducting head-to-head trials, and updating guidance as evidence evolves.
Authors
- Karlijn Burridge
- Angela Golden (ORCID: https://orcid.org/0000-0002-7539-1777)
- Ana María Rojas-Gómez (ORCID: https://orcid.org/0000-0002-9779-338X)
- Brad Hussey (ORCID: https://orcid.org/0009-0008-6915-0599)
- Deborah B. Horn (ORCID: https://orcid.org/0000-0003-3493-9609)
- Jonathan Q. Purnell (ORCID: https://orcid.org/0000-0001-5505-6333)
- Lydia Alexander
- Marc-Andre Cornier
- Camila Ávila-Oliver
- Joe Nadglowski
- Ximena Ramos Salas
- Michelle Look
- Francisco Novillo
Institutions
- Universidad del Desarrollo (CL)
- Medical University of South Carolina (US)
- Oregon Health & Science University (US)
- BirdLife International (KE)
- Clínica Alemana (CL)
- Obesity Society (US)
- Immunization Action Coalition (US)
- Washington Center for Weight Management and Research (US)
- Obesity Medicine Association (US)
- Communications Research Centre Canada (CA)
- San Mateo County Health System (US)
- Universidad Diego Portales (CL)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1016/j.obpill.2026.100254
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00